Trial intelligence / Profile preview

AS101 in mild to moderate psoriasis

NCT00788424Phase 2Withdrawn

Sponsor
BioMAS Ltd
Start
Nov 2008
Primary completion
Feb 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of AS-101 in psoriasis, sponsored by BioMAS Ltd. Planned start Nov 2008; status: withdrawn.

02

Drugs

AS-101
03

Conditions

psoriasis

Beyond the preview

Go deeper on NCT00788424.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00788424.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call